Surgical management of epithelial ovarian cancer: a review of the literature.
Epithelial ovarian cancer affects over 190,000 women worldwide. Over the past 40 years the median survival rate for women affected with this disease has increased from 12 months to 38 months. While advances in chemotherapy have enhanced our armamentarium, optimal cytoreductive surgery by well trained specialists offers the best opportunity for a long disease free interval.
Dupont
N C
NC
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Irvine College of Medicine, Orange, CA 92697, USA.
Berman
M L
ML
D000328:Adult; D001706:Biopsy; D017024:Chemotherapy, Adjuvant; D015331:Cohort Studies; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007044:Hysterectomy; D009367:Neoplasm Staging; D009375:Neoplasms, Glandular and Epithelial / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D010052:Ovariectomy; D010053:Ovary / Q000473:pathology; D011247:Pregnancy; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D012086:Reoperation; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome